FY 2024
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H2401 | Reblozyl | Luspatercept（Genetical Recombination） | H1 | 4/10/2024 | In progress |
| C2H2402 | Truqap | Capivasertib | H1 | 5/15/2024 | In progress |
| C2H2403 | Elrexfio | Elranatamab（Genetical Recombination） | H1 | 5/15/2024 | In progress |
| C2H2404 | Vyloy | Zolbetuximab（Genetical Recombination） | H1 | 5/15/2024 | In progress |
| C2H2405 | Briviact | Brivaracetam | H1 | 8/7/2024 | In progress |
| C2H2406 | Kisunla | Donanemab （Genetical Recombination） |
H1 | 11/13/2024 | In progress |
| C2H2407 | TEPEZZA | Teprotumumab （Genetical Recombination） |
H1 | 11/13/2024 | In progress |
| C2H2408 | Awiqli | Insulin Icodec （Genetical Recombination） |
H1 | 11/13/2024 | In progress |
| C2H2409 | TRODELVY | Sacituzumab Govitecan （Genetical Recombination） |
H2 | 11/13/2024 | In progress |
FY 2023
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H2301 | Besremi | Ropeginterferon Alfa-2b (Genetical Recombination) | H1 | 5/17/2023 | Completed |
| C2H2302 | GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System | Thoracic Stent Graft | H2 | 7/5/2023 | In progress |
| C2H2303 | Litfulo | Ritlecitinib tosylate | H1 | 8/23/2023 | In progress |
| C2H2304 | PHOZEVEL | Tenapanor | H1 | 11/15/2023 | In progress |
| C2H2305 | LEQVIO | Inclisiran | H1 | 11/15/2023 | In progress |
| C2H2306 | Wegovy | Semaglutide | H1 | 11/15/2023 | In progress |
| C2H2307 | EPKINLY | Epcoritamab | H1 | 11/15/2023 | In progress |
| C2H2308 | LEQEMBI | Lecanemab | H1 | 12/13/2023 | In progress |
FY 2022
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H2201 | Lyfnua | Gefapixant Citrate | H1 | 4/13/2022 | Completed |
| C2H2202 | Pivlaz | Clazosentan Sodium | H1 | 4/13/2022 | Completed |
| C2H2203 | Bimzelx | Bimekizumab（Genetical Recombination） | H1 | 4/13/2022 | Completed |
| C2H2204 | Vyvgart | Efgartigimod Alfa（Genetical Recombination） | H1 | 4/13/2022 | Completed |
| C2H2205 | Dysval | Valbenazine Tosilate | H2 | 5/18/2022 | Completed |
| C2H2206 | Kerendia | Finerenone | H1 | 5/18/2022 | Completed |
| C2H2207 | Ondexxya | Andexanet Alfa（Genetical Recombination） | H2 | 5/18/2022 | Completed |
| C2H2208 | Lagevrio | Molnupiravir | H1 | 8/10/2022 | Completed |
| C2H2209 | Sotyktu | Deucravacitinib | H1 | 11/9/2022 | Completed |
| C2H2210 | Tezspire |
Tezepelumab (Genetical Recombination) |
H1 | 11/9/2022 | Completed |
| C2H2211 | Paxlovid |
Nirmatrelvir plus ritonavir |
H1 | 3/8/2023 | In progress |
| C2H2212 | Mounjaro |
Tirzepatide |
H1 | 3/8/2023 | Completed |
| C2H2213 | XOCOVA |
Ensitrelvir Fumaric Acid |
H1 | 3/8/2023 | Completed |
FY 2021
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H2101 | Emgality | Galcanezumab | H1 | 4/14/2021 | Completed |
| C2H2102 | Yescarta | Axicabtagene ciloleucel | H5 | 4/14/2021 | - |
| C2H2103 | Polivy | Polatuzumab Vedotin | H1 | 5/12/2021 | Completed |
| C2H2104 |
Darzquro |
Daratumumab Vorhyaluronidase Alfa |
H1 | 5/12/2021 | Completed |
| C2H2105 |
Arikayce |
Amikacin sulfate | H1 | 5/12/2021 | Completed |
| C2H2106 | Breyanzi | Lisocabtagene maraleucel | H5 | 5/12/2021 | - |
| C2H2107 | Verquvo | Vericiguat | H5 | 8/4/2021 | - |
| C2H2108 | Ajovy | Fremanezumab (Genetical Recombination) | H5 | 8/4/2021 | - |
| C2H2109 | Aimovig | Erenumab (Genetical Recombination) | H5 | 8/4/2021 | - |
| C2H2110 | Revestive | Teduglutide (Genetical Recombination) | H2 | 8/4/2021 | Completed |
| C2H2111 | Veklury | Remdesivir | H1 | 8/4/2021 | Completed |
| C2H2112 | Micra AV | Transcatheter pacing systems | H2 | 10/13/2021 | Completed |
| C2H2113 | Retevmo | Selpercatinib | H1 | 11/17/2021 | Completed |
| C2H2114 | Padcev | Enfortumab vedotin | H1 | 11/17/2021 | Completed |
| C2H2115 | Expedium Verse Fenestrated Screw system | Screw for spinal fusion | H2 | 12/8/2021 | Completed |
FY 2020
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H2001 | Noxafil | Posaconazole | H1 | 4/8/2020 | Completed |
| C2H2002 | Cabometyx | Cabozantinib | H1 | 5/13/2020 | Completed |
| C2H2003 | Enhertu | Trastuzumab Deruxtecan (Genetical Recombination) | H1 | 5/13/2020 | Completed |
| C2H2004 | Zolgensma | Onasemnogene abeparvovec | H3 | 5/13/2020 | |
| C2H2005 | Entresto | Sacubitril Valsartan | H5 | 8/19/2020 | - |
| C2H2006 |
Enerzair |
Indacaterol, Glycopyrronium, Mometasone |
H5 | 8/19/2020 | - |
| C2H2007 |
Rybelsus |
Semaglutide (Genetical Recombination) | H1 | 11/11/2020 | Completed |
| C2H2008 |
Trelegy200 |
Fluticasone, Umeclidinium, Vilanterol | H5 | 2/10/2021 | - |
FY 2019
| ID | Brand name | Generic name | Category | Designated day | Status |
| C2H1901 | Trelegy | Fluticasone, Umeclidinium, Vilanterol | H1 | 05/15/2019 | Completed |
| C2H1902 | Kymriah | Tisagenlecleucel | H3 | 05/15/2019 | Completed |
| C2H1903 | Ultomiris | Ravulizumab | H1 | 08/28/2019 | Completed |
| C2H1904 | Breztri | Budesonide, Glycopyrronium, Formoterol | H5 | 08/28/2019 | - |
| C2H1905 | Trintellix | Vortioxetine | H1 | 11/13/2019 | Completed |
| C2H1906 | Coralan | Ivabradine | H2 | 11/13/2019 | Completed |